You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute Promyelocytic Leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

Recruiting
  • Acute Promyelocytic Leukemia
  • +2 more
  • Beijing, Beijing, China
    Peking University Institute of Hematology
Apr 26, 2023

APL Trial in Shanghai (Chidamide+venetoclax)

Active, not recruiting
  • APL
  • Shanghai, Shanghai, China
    Jiong HU
May 30, 2023

Newly-diagnosed APL (de Novo or Therapy-related), Relapsed APL Trial in Dresden (observational)

Recruiting
  • Newly-diagnosed APL (de Novo or Therapy-related)
  • Relapsed APL
  • observational
  • Dresden, Germany
    Prof. Dr. U. Platzbecker
Aug 10, 2022

The Acute Promyelocytic Leukaemia Asian Consortium Project

Recruiting
  • Acute Promyelocytic Leukemia
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Oct 3, 2022

    Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Birmingham, Alabama
    • +4 more
    Jul 12, 2022

    DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid

    Completed
    • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
    • +8 more
    • Laboratory Biomarker Analysis
    • Philadelphia, Pennsylvania
      Childrens Oncology Group
    Jul 12, 2022

    Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)

    Recruiting
    • Promyelocytic Leukemia
    • Arsenic trioxide
    • all-trans retinoic acid
    • Monterrey, Nuevo Leon, Mexico
      Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
    Aug 9, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    RWE of 1st Line Treatment With ATO/ATRA for Adult APL

    Recruiting
    • Promyelocytic Leukemia, Adult Acute
    • Evaluation of first line treatment with ATO/ATRA outcome
    • Caba, Argentina
    • +1 more
    Nov 9, 2021

    Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Brussels, Belgium
    • +30 more
    Aug 9, 2022

    Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Realgar-Indigo naturalis formula
    • +3 more
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    Aug 31, 2021

    Acute Promyelocytic Leukemia Trial in Canada, United States (Tretinoin and Arsenic Trioxide)

    Completed
    Has Results
    • Acute Promyelocytic Leukemia
    • Tretinoin and Arsenic Trioxide
    • Los Angeles, California
    • +11 more
    Nov 2, 2021

    Leukemia Trial in Tianjin (DNR:, Ara-c)

    Completed
    Has Results
    • Leukemia
    • Tianjin, Tianjin, China
    • +1 more
    Aug 8, 2021

    Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk

    Recruiting
    • Acute Promyelocytic Leukemia
    • Arsenic Trioxide
    • Alessandria, Italy
    • +27 more
    Dec 31, 2021

    Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)

    Completed
    • Leukemia
    • arsenic trioxide
    • +5 more
    • Innsbruck, Austria
    • +109 more
    Oct 10, 2022

    Results From a Mexican Acute Promyelocytic Leukemia.

    Completed
    • Promyelocytic Leukemia, Acute
    • Diagnosis
    • +2 more
    • Mexico, Mexico City, Mexico
      Nidia Zapata
    Sep 18, 2020

    Acute Promyelocytic Leukemia Trial in Hong Kong (Oral arsenic Trioxide, ATRA and ascorbic acid)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Oral arsenic Trioxide, ATRA and ascorbic acid
    • Hong Kong, N/A = Not Applicable, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Nov 3, 2020

    Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO

    Active, not recruiting
    • Acute Promyelocytic Leukemia
    • QoL questionnaires
    • Ascoli Piceno, Italy
    • +15 more
    Feb 3, 2021

    Acute Promyelocytic Leukemia Trial in Hong Kong (Oral Arsenic Trioxide Formulation)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Oral Arsenic Trioxide Formulation
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Dec 29, 2020

    Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

    Active, not recruiting
    • Leukemia
    • +2 more
    • laboratory biomarker analysis
    • San Diego, California
    • +50 more
    Aug 16, 2021

    Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • +5 more
    • Biopsy
    • +7 more
    • Lewes, Delaware
    • +42 more
    Mar 15, 2022

    Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in

    Active, not recruiting
    Has Results
    • Childhood Acute Promyelocytic Leukemia (M3)
    • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    • arsenic trioxide
    • +7 more
    • Birmingham, Alabama
    • +110 more
    Mar 23, 2022

    Acute Promyelocytic Leukemia Trial in Bari, Pavia, Roma (all-trans retinoic acid (ATRA))

    Recruiting
    • Acute Promyelocytic Leukemia
    • all-trans retinoic acid (ATRA)
    • Bari, Italy
    • +2 more
    Oct 12, 2020

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed

    Recruiting
    • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
    • MRD-triggered arm
    • Prophylactic Arm
    • Heidelberg, BW, Germany
      University Hospital Heidelberg Med5
    Jan 4, 2021